Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians? - Wikidata - awgldk - TriplyDB

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

http://www.wikidata.org/entity/Q52597638

about

Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review.

P2860

Q55489605-B8492F7D-FE9C-4D5F-9C64-C0B8DD48D21E

P2860

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

http://www.wikidata.org/entity/Q52597638

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

@en

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

@nl

type

label

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

@en

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

@nl

prefLabel

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

@en

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

@nl

P1433

Q52597638-4CFBEFC7-5E8E-4985-8A0B-DEB1E138BCF8

P1476

Q52597638-A72BCB89-AFE8-48CA-AFE3-46134D65A37A

P2093

Q52597638-1BFF2F35-63FA-41A3-9D8A-D8881BC8FB0A

Q52597638-325D76FD-8D8F-440A-86A2-68D9C223BCC5

Q52597638-328FE2DE-0659-4BB2-B92C-A69F641C8F78

Q52597638-426988DD-4A27-4D9C-8EA5-AFF85FE5D4CD

Q52597638-72549DE2-F527-4A86-950D-A579602AF376

Q52597638-DA6DF710-0395-40EE-A0DF-B421F2C8C2A3

Q52597638-E035A91B-23A6-4EE7-9F12-AB7B10FA532E

P275

Q52597638-557B1194-7543-491E-8875-8BC19665186F

P2860

Q52597638-00AFD4FB-D959-4F0F-BD94-997B1AB41B4F

Q52597638-01F1D5E4-F415-4D51-873A-F3B789630069

Q52597638-026A6A00-F46D-4DAF-A8A8-648A71948942

Q52597638-02BDD8DD-BB12-4D53-AC8E-85DA66D6B693

Q52597638-0388DA0C-1F41-496A-AE6C-B904A597ADB2

Q52597638-0447174A-ADFA-4879-9481-6B7325F9F68F

Q52597638-067F3E87-889E-417C-89DC-2B5D309370FF

Q52597638-071DD842-FEAC-4A4B-8A94-3604801956CD

Q52597638-078D66DA-33F4-45A2-A9BC-7A1A1C05BD4B

Q52597638-087D8CD9-AD3A-4D41-B67F-1CFC1B31270A

P304

Q52597638-6DB621A7-8007-44E6-AC21-DF9760A0E73C

P31

Q52597638-23284CE2-2214-4F79-BEB8-78736A52EB35

Q52597638-27D8F588-2574-4DB4-A65F-1B8EBB843D2F

P356

Q52597638-E774CBC9-58C7-4F0E-BF0A-57996B4E85D3

P478

Q52597638-299344E2-E3E2-4644-9B66-800C1915F47E

P577

Q52597638-173C365E-870C-4291-92DC-DBB97ABADA67

P698

Q52597638-1C7FEC67-233F-4152-B800-2EE70C6A1776

P921

Q52597638-3BFF0B0C-6E22-4F23-B8C2-1B477224F833

Q52597638-6D874FD0-C16E-4B1F-A998-3F81D592DD67

Q52597638-87D857F4-7E5A-416F-BB4E-4B5D2ACC1145

Q52597638-8E8E6621-B80D-4D08-B613-24BC179FC343

Q52597638-C724C76A-655F-4428-AD17-10F750BB8C10

P932

Q52597638-96C775D4-4B86-4E29-A55C-D42BD4A16DA7

P356

FIMMU.2018.00541

P1433

Frontiers in Immunology

P1476

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

@en

P2093

Ailsa Robbins

http://www.w3.org/2001/XMLSchema#string

Amelie Servettaz

http://www.w3.org/2001/XMLSchema#string

Delphine Giusti

http://www.w3.org/2001/XMLSchema#string

Frank Antonicelli

http://www.w3.org/2001/XMLSchema#string

Kevin Didier

http://www.w3.org/2001/XMLSchema#string

Loïs Bolko

http://www.w3.org/2001/XMLSchema#string

Segolene Toquet

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

Anti-keratin antibodies in rheumatoid arthritis

Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

P304

541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.00541

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29632529

http://www.w3.org/2001/XMLSchema#string

P921

connective tissue disease

connective tissue

P932

5879136

http://www.w3.org/2001/XMLSchema#string